David John Roth
Director of Finance/CFO en 4BASEBIO PLC .
Fortuna: - $ al 31/03/2024
Perfil
David John Roth is currently a Director at Expedeon Holdings Ltd., a Director at 4basebio UK Ltd., a CFO, Secretary & Executive Director at 4basebio Plc, and a Non-Executive Director at Heqet Therapeutics SRL.
Previously, he worked as a Director at Arthur Andersen LLP and as the Chief Financial Officer at 2invest AG from 2017 to 2020.
He obtained his undergraduate degree from the University of Hertfordshire.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
4BASEBIO PLC
-.--% | 31/12/2022 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de David John Roth
| Empresas | Cargo | Inicio |
|---|---|---|
| 4BASEBIO PLC | Director of Finance/CFO | 22/12/2020 |
4basebio UK Ltd.
 4basebio UK Ltd. Wholesale DistributorsDistribution Services 4basebio Ltd. engages in the genomics and DNA manufacturing business. The company was founded on November 5, 2019 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 05/11/2019 |
Expedeon Holdings Ltd.
 Expedeon Holdings Ltd. BiotechnologyHealth Technology Expedeon Holdings Ltd. develops, manufactures, and commercializes proteomics reagents and tools. The company was founded on January 7, 2009 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 28/09/2017 |
Heqet Therapeutics SRL
 Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Heqet Therapeutics SRL is an Italian biotechnology company that specializes in cardiac regenerative medicine. The company is based in Turin, Italy. The company was founded by Mauro Giacca. Marta Antonucci has been the CEO of the company since 2022. | Director/Board Member | - |
Antiguos cargos conocidos de David John Roth.
| Empresas | Cargo | Fin |
|---|---|---|
| 2INVEST AG | Director of Finance/CFO | 30/12/2020 |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Director/Board Member | - |
Formación de David John Roth.
| University of Hertfordshire | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| 2INVEST AG | Finance |
| 4BASEBIO PLC | Health Technology |
| Empresas privadas | 4 |
|---|---|
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
Expedeon Holdings Ltd.
Expedeon Holdings Ltd. BiotechnologyHealth Technology Expedeon Holdings Ltd. develops, manufactures, and commercializes proteomics reagents and tools. The company was founded on January 7, 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
4basebio UK Ltd.
4basebio UK Ltd. Wholesale DistributorsDistribution Services 4basebio Ltd. engages in the genomics and DNA manufacturing business. The company was founded on November 5, 2019 and is headquartered in Cambridge, the United Kingdom. | Distribution Services |
Heqet Therapeutics SRL
Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Heqet Therapeutics SRL is an Italian biotechnology company that specializes in cardiac regenerative medicine. The company is based in Turin, Italy. The company was founded by Mauro Giacca. Marta Antonucci has been the CEO of the company since 2022. | Health Technology |
- Bolsa de valores
- Insiders
- David John Roth
